| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $5.46B | +6.2% |
| Cost of Revenue | $3.06B | +4.7% |
| Gross Profit | $2.40B | +8.3% |
| R&D Expense | $107.6M | +3.8% |
| SG&A Expense | $1.33B | +6.5% |
| Operating Income | $866.6M | +3.7% |
| Pre-tax Income | $796.2M | +13.3% |
| Income Tax | $184.7M | +23.5% |
| Net Income | $614.6M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.04B | +3.5% |
| Inventory | $581.3M | -13.8% |
| Current Assets | $2.00B | -30.3% |
| Total Assets | $10.15B | -8.3% |
| Current Liabilities | $1.02B | +9.8% |
| Long-term Debt | $1.92B | -38.5% |
| Total Liabilities | $3.53B | -25.6% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.15B | +18.0% |
| Capital Expenditures | $370.1M | +2.7% |
| Investing Cash Flow | $388.8M | +143.8% |
| Financing Cash Flow | -$1.57B | -1745.8% |
| Free Cash Flow | $778.0M | +26.9% |
| +62.5% |
| EPS (Basic) | $6.24 | +62.9% |
| EPS (Diluted) | $6.20 | +62.7% |
| Stockholders' Equity |
| $6.60B |
| +4.8% |